Enhua Pharmaceutical Industry: The registration and listing application of innovative drug NH600001 emulsion injection has been accepted.

On August 20th, it was reported that the National Medical Products Administration has accepted the registration application for NH600001 emulsion injection, a Class 1 innovative drug independently developed by Enhua Pharmaceutical. This drug is indicated for general anesthesia induction and short-term surgical anesthesia.